Bisoprolol hemifumarate

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

51 API Suppliers, 14 USDMF, 16 CEP/COS, 8 JDMF, 13 EU WC, 3 KDMF, 10 NDC API, 38 Listed Suppliers

DEVELOPMENTS

3 Drug(s) in Development

3 Drug(s) in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

INTERMEDIATES

10 Suppliers

10 Suppliers

DOSSIERs // Finished Dosage Formulations

587 Dossiers, 66 FDA Orange Book, 278 Europe, 20 Canada, 54 Australia, 61 South Africa, 108 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers, 21 Kerry, 16 BASF, 16 Roquette, 13 Seppic, 10 Gangwal Chemicals, 10 Microlex e.U, 10 Corel Pharma Chem, 9 Sigachi Industries, 7 Gangwal Healthcare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 Lonza Capsugel, 5 Ideal Cures Pvt Ltd, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 5 Actylis, 4 SPI Pharma, 4 DFE Pharma, 3 Prachin Chemical, 3 Vasa Pharmachem, 3 Nanjing Well Pharmaceutical, 3 Ingredion Pharma Solutions, 3 Kima Chemical, 2 The Dow Chemical Company, 2 Jai Radhe Sales, 2 Boai NKY Pharmaceuticals Ltd, 2 Nomisma Healthcare, 2 Seqens, 1 Huzhou Sunflower Pharmaceutical, 1 Alcedo Pharmachem, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 ACG Worldwide, 1 Qualicaps, 1 Clariant, 1 Nanjing Bold Chemical, 1 Pharmatrans-Sanaq, 1 Finar

EXCIPIENTS BY APPLICATIONS

47 Fillers, Diluents & Binders, 45 Coating Systems & Additives, 26 Direct Compression, 26 Controlled & Modified Release, 19 Disintegrants & Superdisintegrants, 18 Thickeners and Stabilizers, 17 Solubilizers, 16 Granulation, 14 Film Formers & Plasticizers, 13 Lubricants & Glidants, 13 Topical, 10 Co-Processed Excipients, 10 Taste Masking, 8 Parenteral, 6 Emulsifying Agents, 6 Chewable & Orodispersible Aids, 5 Empty Capsules, 5 API Stability Enhancers, 5 Rheology Modifiers, 4 Vegetarian Capsules, 3 Surfactant & Foaming Agents, 2 Coloring Agents

GLOBAL SALES INFORMATION

14 US Medicaid Prescriptions, 204 Finished Drug Prices

MARKET PLACE

27 APIs, 22 DOSSIERS // FDF

REF. STANDARDS & IMPURITIES

4 BioAnalytical Methods, 3 EDQM, 1 USP, 11 Others

DIGITAL CONTENT

1 Data Compilations & Company Tracker #PharmaFlow, 18 News

List of Suppliers

Full Screen View

Reset Filter

Price Info

Polpharma

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Poland

Virtual Booth

Digital Content

4-hydroxybenzyl alcohol

PDF Supplier PDF

URL Supplier Web Content

CAS Number

623-05-2

End Use API

Bisoprolol Fumarate

About The Company

Polpharma is a Poland-based CDMO and API producer. With over 70 years of experience, it is Poland's bigge...

Polpharma is a Poland-based CDMO and API producer. With over 70 years of experience, it is Poland's biggest API manufacturer. It provides its customers with materials ranging from clinical quantities up to market supply. Polpharma has fully integrated all of its operations, from R&D to manufacturing, leveraging all its key competencies to deliver cost-effective and on-time solutions to its customers. It manufactures APIs at a cGMP-compliant and FDA-approved multipurpose plant. It has invested US$ 45 million to expand its API plant in Starogard Gdanski to include HPAPI and cryogenic technologies, as well as a pilot plant and R&D capabilities.

BOS Basel 2024

Attending

envelop Contact Supplier

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

List of Suppliers of Bisoprolol hemifumarate intermediates listed on PharmaCompass.com

Bisoprolol Hemifumarate

Bisoprolol hemifumarate

Synopsis

Chemistry

APIs // Active Pharmaceutical Ingredients

51 API Suppliers

14 USDMF

16 CEP/COS

8 JDMF

13 EU WC

3 KDMF

10 NDC API

38 Listed Suppliers

DEVELOPMENTS

3 Drug(s) in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

10 Suppliers

DOSSIERs // Finished Dosage Formulations

587 Dossiers

66 FDA Orange Book

278 Europe

20 Canada

54 Australia

61 South Africa

108 Listed Dossiers

DRUG PRODUCT COMPOSITION

TABLET;ORAL - 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

Suppliers

21 Kerry

16 BASF

16 Roquette

13 Seppic

10 Gangwal Chemicals

10 Microlex e.U

10 Corel Pharma Chem

9 Sigachi Industries

7 Gangwal Healthcare

7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

6 Lonza Capsugel

5 Ideal Cures Pvt Ltd

5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

5 Actylis

4 SPI Pharma

4 DFE Pharma

3 Prachin Chemical

3 Vasa Pharmachem

3 Nanjing Well Pharmaceutical

3 Ingredion Pharma Solutions

3 Kima Chemical

2 The Dow Chemical Company

2 Jai Radhe Sales

2 Boai NKY Pharmaceuticals Ltd

2 Nomisma Healthcare

2 Seqens

1 Huzhou Sunflower Pharmaceutical

1 Alcedo Pharmachem

1 Qianhao Chemical (Hebei) Co., Ltd

1 ACG Worldwide

1 Qualicaps

1 Clariant

1 Nanjing Bold Chemical

1 Pharmatrans-Sanaq

1 Finar

EXCIPIENTS BY APPLICATIONS

47 Fillers, Diluents & Binders

45 Coating Systems & Additives

26 Direct Compression

26 Controlled & Modified Release

19 Disintegrants & Superdisintegrants

18 Thickeners and Stabilizers

17 Solubilizers

TABLET;ORAL - 10MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons